The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.
Bevacizumab to Oxaliplatin Based Chemotherapy : Impact on Hepatic Sinusoidal Injury and Thrombocytopenia